Lingotto Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$135M |
| 2 |
VEON
VEON
|
+$103M |
| 3 |
Valaris
VAL
|
+$47.4M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$35.8M |
| 5 |
NovaGold Resources
NG
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$113M |
| 2 |
Cameco
CCJ
|
+$108M |
| 3 |
Liberty Energy
LBRT
|
+$60.4M |
| 4 |
Range Resources
RRC
|
+$47.4M |
| 5 |
Weatherford International
WFRD
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 39.73% |
| 2 | Communication Services | 29.76% |
| 3 | Materials | 20.12% |
| 4 | Healthcare | 7.05% |
| 5 | Industrials | 0.22% |
Similar funds
Lingotto Investment Management's Q4 2021 Portfolio in Review
As of Q4 2021, Lingotto Investment Management held 20 positions worth $1.33B, up 5% from $1.27B the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Lingotto Investment Management deployed $58.4M of net new capital in Q4 2021, opening 6 new positions and adding to 7 existing holdings. Its largest new stake was Teva Pharmaceuticals: 15,008,389 shares worth $93.9M.
By sector, the portfolio is most concentrated in Energy at 40% of assets, down from 61% a quarter earlier, followed by Communication Services and Materials.
On the sell side, the largest reduction was SLB Ltd, an estimated $113M trimmed.
- Lingotto Investment Management's largest Q4 2021 buy was Teva Pharmaceuticals: 15,008,389 shares worth $93.9M.
- Lingotto Investment Management added most to VEON in Q4 2021, an estimated $103M increase.
- Lingotto Investment Management's biggest Q4 2021 reduction was SLB Ltd, cutting an estimated $113M.
- Lingotto Investment Management fully exited Liberty Energy in Q4 2021, selling an estimated $60.4M.
- Lingotto Investment Management's ten largest holdings make up 96% of its $1.33B portfolio in Q4 2021.
- Lingotto Investment Management opened 6 new positions and closed 2 in Q4 2021.
- Lingotto Investment Management's portfolio value rose 5% quarter-over-quarter to $1.33B.
Based on Lingotto Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.